Other
Platelet lysate
Platelet lysate is an intervention with 5 clinical trials. Historical success rate of 66.7%.
Total Trials
5
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_1
4
80%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
4(80.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(2)
Terminated(1)
Other(2)
Detailed Status
unknown2
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
66.7%
Most Advanced
Phase 1
Trials by Phase
Phase 14 (80.0%)
N/A1 (20.0%)
Trials by Status
terminated120%
unknown240%
completed240%
Recent Activity
0 active trials
Showing 5 of 5
terminatednot_applicable
Platelet Lysate vs Saline for Lumbosacral Radiculopathy
NCT06924853
completedphase_1
Autologous Platelet Lysate in Corneal Epithelial Defects
NCT02979912
unknownphase_1
The Use of Allogenic Platelet Rich Plasma for the Treatment of Diabetic Foot Ulcer
NCT02972528
unknownphase_1
Use of Allogenic Platelet Lysate in Peripheral Arterial Disease (PAD)
NCT03297814
completedphase_1
Treatment of PAD by Platelet Lysate for Therapeutic Angiogenesis
NCT02941419
Clinical Trials (5)
Showing 5 of 5 trials
NCT06924853Not Applicable
Platelet Lysate vs Saline for Lumbosacral Radiculopathy
NCT02979912Phase 1
Autologous Platelet Lysate in Corneal Epithelial Defects
NCT02972528Phase 1
The Use of Allogenic Platelet Rich Plasma for the Treatment of Diabetic Foot Ulcer
NCT03297814Phase 1
Use of Allogenic Platelet Lysate in Peripheral Arterial Disease (PAD)
NCT02941419Phase 1
Treatment of PAD by Platelet Lysate for Therapeutic Angiogenesis
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5